| |
 |
Editorial [Hot Topic: Therapeutic Targeting of the Sphingolipid “Biostat” in Hematologic Malignancies (Guest Editors: Thomas P. Loughran and Hong-Gang Wang)]
|
| |
|
pp.780-781 (2) Authors: Thomas P. Loughran, Hong-Gang Wang |
| |
|
|
| |
 |
Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond
|
| |
|
pp.782-793 (12) Authors: Kenneth C. Loh, Dianna Baldwin, Julie D. Saba |
| |
|
|
| |
 |
Targeting Sphingosine-1-Phosphate in Hematologic Malignancies
|
| |
|
pp.794-798 (5) Authors: Christina E. Stevenson, Kazuaki Takabe, Masayuki Nagahashi, Sheldon Milstien, Sarah Spiegel |
| |
|
|
| |
 |
Regulation of Sphingosine Kinase in Hematological Malignancies and Other Cancers
|
| |
|
pp.799-809 (11) Authors: Stuart M. Pitson, Jason A. Powell, Claudine S. Bonder |
| |
|
|
| |
 |
Targeting Sphingosine-1-Phosphate Receptors in Cancer
|
| |
|
pp.810-817 (8) Authors: Rebecca J. Watters, Hong-Gang Wang, Shen-Shu Sung, Thomas P. Loughran, Xin Liu |
| |
|
|
| |
 |
S1P Regulation of Macrophage Functions in the Context of Cancer
|
| |
|
pp.818-829 (12) Authors: Andreas Weigert, Benjamin Weichand, Bernhard Brune |
| |
|
|
| |
 |
Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
|
| |
|
pp.830-843 (14) Authors: Gemma Fabrias, Carmen Bedia, Josefina Casas, Jose Luis Abad, Antonio Delgado |
| |
|
|
| |
 |
Regulation of Autophagy by Sphingolipids
|
| |
|
pp.844-853 (10) Authors: Carmen Bedia, Thierry Levade, Patrice Codogno |
| |
|
|
| |
 |
Hypoxia-Inducible Factors and Sphingosine 1-Phosphate Signaling
|
| |
|
pp.854-862 (9) Authors: Olivier Cuvillier, Isabelle Ader |
| |
|
|
| |
 |
Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
|
| |
|
pp.863-881 (19) Authors: Tara Ann Burns, Chiara Luberto |
| |
|
|
| |
 |
The Gut-To-Breast Connection - Interdependence of Sterols and Sphingolipids in Multidrug Resistance and Breast Cancer Therapy
|
| |
|
pp.882-890 (9) Authors: Stefka Spassieva, Erhard Bieberich |
| |
|
|
| |
 |
Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies
|
| |
|
pp.891-903 (13) Authors: Valerie Gouaze-Andersson, Myles C. Cabot |
| |
|
|
| |
 |
Ceramide Transfer Protein and Cancer
|
| |
|
pp.904-910 (7) Authors: Luana Scheffer, Pralhada Rao Raghavendra, Jingjing Ma, Jairaj K. Acharya |
| |
|
|
| |
 |
Ceramide-Based Therapeutics for the Treatment of Cancer
|
| |
|
pp.911-919 (9) Authors: Brian M. Barth, Myles C. Cabot, Mark Kester |
| |
|
|